Hi Brett.
you call it dreaming
I like to use the term vision
all the same dreams have been responsible for some major creative and scientific discoveries in the course of human history.
I think its a privledge to be able to participate in the same vision as that of our scientific advisary board, directors and CEO in whom I see as a person of good charactor, ethos highly experianced and motivated, ( on that account the following video is worth seeing)
Thier vision is to help transform and improve the treatment of cancer and the lives of the millions of patients whom need effective treatments. This vision is backed by a growing body of clinical evidence and peer-reviewedresearch.
Imugene is well funded and resourced, to deliver on its commercial and clinical milestones. Together with leading specialists and medical professionals, we believe Imugene’s immuno-oncology therapies willbecome a foundation treatment for cancer. The goal is to ensure that Imugene and its shareholders are at theforefront of this rapidly growing global market.
that is our Vision
kind regards
fp
- Forums
- ASX - By Stock
- IMU
- Ann: IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx
Ann: IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx, page-33
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M |
Open | High | Low | Value | Volume |
3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2275218 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 196677 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5665336 | 0.018 |
14 | 3997559 | 0.017 |
6 | 2974375 | 0.016 |
10 | 3219799 | 0.015 |
4 | 497500 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 400000 | 2 |
0.020 | 5410946 | 12 |
0.021 | 8494780 | 17 |
0.022 | 8757253 | 13 |
0.023 | 4826614 | 8 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
IMU (ASX) Chart |